Vaccine Response to COVID-19 Vaccines in Patients Using Immunosuppressive Medication

Active, not recruitingOBSERVATIONAL

Enrollment

2,300

Participants

Timeline

Start Date

February 15, 2021

Primary Completion Date

February 15, 2026

Study Completion Date

February 15, 2027

Conditions

Rheumatoid ArthritisPsoriatic ArthritisSpondyloarthritisCrohn DiseaseUlcerative ColitisAutoimmune HepatitisLiver Transplant; Complications

Trial Locations (2)

Akershus University Hospital, Lørenskog

Diakonhjemmet Hospital, Oslo

All Listed Sponsors

collaborator

University Hospital, Akershus

OTHER

lead

Diakonhjemmet Hospital

OTHER